2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline

2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline Suppliers list
Company Name: Shanghai Cuisen Pharmaceutical Technology Co., Ltd.  
Tel: 13472757003
Email: yongnan.wang@cendrix.cn
Company Name: Shanghai Witofly Chemical Co.,Ltd  
Tel:
Email: sales@witofly.com
Company Name: Shanghai HuanChuan Industry Co.,Ltd.  
Tel: 021-61478794
Email: sales@hcshhai.com
Company Name: Cool Pharm, Ltd  
Tel: 021-60455363 18019463053
Email: sales@coolpharm.com
Company Name: Zhengzhou Alfachem Co., Ltd.  
Tel: 0371-53765687 18937137882
Email: 3969243885@qq.com
2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline Basic information
Product Name:2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline
Synonyms:Spiro[piperidine-4,4'(1'H)-quinazolin]-2'(3'H)-one;1'H-Spiro[piperidine-4,4'-quinazolin]-2'(3'H)-one;1'H-spiro[piperidine-4,4'(1'H)-quinazolin]-2'(3'H)-one;spiro[1,3-dihydroquinazoline-4,4'-piperidine]-2-one;2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline
CAS:635713-68-7
MF:C12H15N3O
MW:217.27
EINECS:
Product Categories:
Mol File:635713-68-7.mol
2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline Structure
2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline Chemical Properties
Boiling point 371.3±42.0 °C(Predicted)
density 1.26±0.1 g/cm3(Predicted)
storage temp. under inert gas (nitrogen or Argon) at 2–8 °C
pka11.77±0.20(Predicted)
Safety Information
MSDS Information
2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline Usage And Synthesis
Synthesis
Spiro[piperidine-4,4'(1'H)-quinazolin]-2'(3'H)-one, 1-(phenylmethyl)-

635713-67-6

2'',3''-DIHYDRO-2''-OXOSPIRO-[PIPERIDINE-4,4''(1H'')-QUINAZOLINE

635713-68-7

The general procedure for the synthesis of 1'H-spiro[piperidine-4,4'-quinazolin]-2'(3'H)-ones was carried out as follows, using 1-benzyl-1'H-spiro[piperidine-4,4'-quinazolin]-2'(3'H)-ones as starting material: 1-benzyl-1'H-spiro[piperidine-4,4'-quinazolin]-2'(3'H)-ones (1.00 g) were dissolved in degassed methanol (50 ml ), 6N hydrochloric acid (2.0 ml) was added followed by 10% palladium carbon catalyst (150 mg). The reaction mixture was placed in a Parr hydrogenation unit and the reaction was shaken at 60 psi hydrogen pressure overnight. The progress of the reaction was monitored by LC/MS and the reaction was found to be incomplete. The 10% palladium carbon catalyst (200 mg) was added additionally and the reaction was continued with oscillation under the same conditions for 2 days. Upon completion of the reaction, the catalyst was removed by filtration and the filtrate was concentrated to afford the target product 1'H-spiro[piperidin-4,4'-quinazolin]-2'(3'H)-one (531 mg, 64% yield). Mass spectrometry analysis showed a molecular ion peak of 218.12 (MH+).

References[1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 14, p. 4719 - 4722
[2] Patent: WO2003/104236, 2003, A1. Location in patent: Page 58
[3] Patent: US2005/215576, 2005, A1. Location in patent: Page/Page column 19
2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline Preparation Products And Raw materials
Raw materialsSpiro[piperidine-4,4'(1'H)-quinazolin]-2'(3'H)-one, 1-(phenylmethyl)--->Hydrochloric acid-->Methanol-->Hydrogen-->Water
Tag:2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline(635713-68-7) Related Product Information
1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one 2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline N-Methyl-4-phenyl-4-piperidinamine 1'H-Spiro[piperidine-4,4'-quinazolin]-2'(3'H)-one hydrochloride Spiro[cyclohexane-1,4'(1'H)-quinazolin]-2'(3'H)-one, 8'-chloro- 8'-chloro-5'-hydroxy-1'H-spiro[cyclohexane-1,4'-quinazolin]-2'(3'H)-one